You are here

  • Home
  • Archive
  • Volume 35, Issue 8
  • Intravenous cefazolin plus oral probenecid versus oral cephalexin for the treatment of skin and soft tissue infections: a double-blind, non-inferiority, randomised controlled trial

Article metrics

Article menu
Download PDFPDF
Original article
Intravenous cefazolin plus oral probenecid versus oral cephalexin for the treatment of skin and soft tissue infections: a double-blind, non-inferiority, randomised controlled trial

 

Online download statistics by month:

Online download statistics by month: June 2018 to March 2024

AbstractFullPdf
Jun 20185533844
Jul 2018111610881
Aug 20185505430
Sep 20183437442
Oct 20182503726
Nov 20183202022
Dec 20182051626
Jan 20192743632
Feb 20192252421
Mar 20194052219
Apr 20192852320
May 20192422236
Jun 20191761521
Jul 2019235928
Aug 20191962023
Sep 20192653129
Oct 20193061529
Nov 20193082438
Dec 20192101714
Jan 20202382413
Feb 2020198145
Mar 20202111215
Apr 20201811714
May 20201942414
Jun 20201993014
Jul 20201961921
Aug 20201972313
Sep 20202922525
Oct 202026687
Nov 20202342024
Dec 20202441623
Jan 2021269166
Feb 20213212126
Mar 20212741920
Apr 20212651415
May 202195205
Jun 20211395
Jul 202119164
Aug 202125164
Sep 202134308
Oct 2021207911
Nov 20213091813
Dec 2021200176
Jan 2022211244
Feb 2022362123
Mar 2022211149
Apr 2022202148
May 20222602719
Jun 2022222183
Jul 2022242138
Aug 2022276197
Sep 2022329225
Oct 2022321225
Nov 2022307255
Dec 2022270152
Jan 2023463204
Feb 2023525195
Mar 2023401206
Apr 2023528167
May 2023516235
Jun 2023444134
Jul 2023452102
Aug 2023393181
Sep 2023480158
Oct 2023502203
Nov 2023389133
Dec 2023398118
Jan 202492213
Feb 2024243228
Mar 2024356328
Total2054015211055